Your browser doesn't support javascript.
loading
Distinct Features of Autoimmune Gastritis in Patients with Open-Type Chronic Gastritis in Japan.
Tsuboi, Mayo; Niikura, Ryota; Hayakawa, Yoku; Hirata, Yoshihiro; Ushiku, Tetsuo; Koike, Kazuhiko.
Afiliación
  • Tsuboi M; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Niikura R; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Hayakawa Y; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Hirata Y; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 108-863, Japan.
  • Ushiku T; Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
  • Koike K; Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Biomedicines ; 8(10)2020 Oct 14.
Article en En | MEDLINE | ID: mdl-33066474
In Asia, the incidences of Helicobacter pylori infection and gastric cancer are high, but their association with autoimmune gastritis (AIG) is unclear. This was a retrospective cohort study of patients endoscopically diagnosed with chronic gastritis between 2005 and 2017. AIG was diagnosed according to anti-parietal cell antibody positivity. Laboratory, histological findings, and gastric cancer incidence were compared between AIG and non-AIG patients. The AIG group had more females and a higher rate of thyroid disease. Serum levels of gastrin were significantly higher in AIG patients (mean 1412 and 353 pg/mL, p < 0.001). The endoscopic findings included a significantly higher percentage of corpus-dominant atrophy in AIG (31.67%) than in non-AIG (7.04%) patients (p < 0.001). Clusters of ECL cells were observed in 28% of AIG patients and 7% of non-AIG patients (p = 0.032). The cumulative incidence of gastric cancer at 5 and 10 years was 0% and 0.03% in the AIG group and 0.03% and 0.05% in the non-AIG group, and no significant difference in gastric cancer incidence was observed. Despite significant differences in gastrin levels between AIG and non-AIG patients, there was no evidence of an impact of AIG on the incidence of gastric cancer.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Biomedicines Año: 2020 Tipo del documento: Article